View Single Post
Old 01-05-2021, 03:24 PM   #1
Senior Member
Join Date: Nov 2005
Posts: 324
ARX788: A potential new treatment after T-DM1, Enhertu.

For some reason I can not post in "Articles of interest" section.

ARX788, a Site-specific anti-HER2 Antibody Drug Conjugate, Demonstrates Potent and Selective Activity in HER2 Low and T-DM1 Resistant Breast and Gastric Cancers
Nguyen is offline   Reply With Quote